Does ASPIRIN DL-LYSINE Cause Hyperglycaemia? 7 Reports in FDA Database

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperglycaemia have been filed in association with ASPIRIN DL-LYSINE. This represents 0.1% of all adverse event reports for ASPIRIN DL-LYSINE.

How Dangerous Is Hyperglycaemia From ASPIRIN DL-LYSINE?

Of the 7 reports, 1 (14.3%) required hospitalization.

Is Hyperglycaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ASPIRIN DL-LYSINE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does ASPIRIN DL-LYSINE Cause?